159 related articles for article (PubMed ID: 2962514)
1. Lowering of plasma glucose in diabetic rats by antilipolytic agents.
Reaven GM; Chang H; Ho H; Jeng CY; Hoffman BB
Am J Physiol; 1988 Jan; 254(1 Pt 1):E23-30. PubMed ID: 2962514
[TBL] [Abstract][Full Text] [Related]
2. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
Reaven GM; Chang H; Hoffman BB
Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
[TBL] [Abstract][Full Text] [Related]
3. Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine.
Hoffman BB; Dall'Aglio E; Hollenbeck C; Chang H; Reaven GM
J Pharmacol Exp Ther; 1986 Dec; 239(3):715-8. PubMed ID: 3795036
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.
Dhalla AK; Santikul M; Chisholm JW; Belardinelli L; Reaven GM
Diabetes Obes Metab; 2009 Feb; 11(2):95-101. PubMed ID: 18494808
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes.
Hoffman BB; Chang H; Dall'Aglio E; Reaven GM
J Clin Invest; 1986 Jul; 78(1):185-90. PubMed ID: 3013937
[TBL] [Abstract][Full Text] [Related]
6. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue.
Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057
[TBL] [Abstract][Full Text] [Related]
7. Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation.
Hoffman BB; Prokocimer P; Thomas JM; Vagelos R; Chang H; Reaven GM
Endocrinology; 1989 May; 124(5):2434-42. PubMed ID: 2539980
[TBL] [Abstract][Full Text] [Related]
8. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
[TBL] [Abstract][Full Text] [Related]
9. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
Blachère JC; Pérusse F; Bukowiecki LJ
Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
[TBL] [Abstract][Full Text] [Related]
10. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
[TBL] [Abstract][Full Text] [Related]
11. Basal lipolysis in epididymal fat cells from streptozotocin-induced diabetic rats.
Tsujita T
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):47-53. PubMed ID: 16637229
[TBL] [Abstract][Full Text] [Related]
12. Evidence for impaired coupling of receptors to Gi protein in adipocytes from streptozocin-induced diabetic rats.
Green A; Johnson JL
Diabetes; 1991 Jan; 40(1):88-94. PubMed ID: 1849851
[TBL] [Abstract][Full Text] [Related]
13. Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations.
Koopmans SJ; Sips HC; Bosman J; Radder JK; Krans HM
Endocrinology; 1989 Dec; 125(6):3044-50. PubMed ID: 2684615
[TBL] [Abstract][Full Text] [Related]
14. Diabetes decreases sensitivity of adipocyte lipolysis to inhibition by Gi-linked receptor agonists.
Saggerson D; Orford M; Chatzipanteli K; Shepherd J
Cell Signal; 1991; 3(6):613-24. PubMed ID: 1786208
[TBL] [Abstract][Full Text] [Related]
15. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
Yki-Järvinen H; Taskinen MR
Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.
Koopmans SJ; Sips HC; Krans HM; Radder JK
Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988
[TBL] [Abstract][Full Text] [Related]
17. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
18. Gi down-regulation as a mechanism for heterologous desensitization in adipocytes.
Green A; Milligan G; Dobias SB
J Biol Chem; 1992 Feb; 267(5):3223-9. PubMed ID: 1737778
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenosine deaminase, N6-phenylisopropyladenosine and hypothyroidism on the responsiveness of rat brown adipocytes to noradrenaline.
Woodward JA; Saggerson ED
Biochem J; 1986 Sep; 238(2):395-403. PubMed ID: 3800944
[TBL] [Abstract][Full Text] [Related]
20. Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist.
Green A
J Biol Chem; 1987 Nov; 262(32):15702-7. PubMed ID: 3680221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
